BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2246406)

  • 1. Use of Mohs micrographic surgery to establish quantitative proof of heightened tumor spread in basal cell carcinoma recurrent following radiotherapy.
    Smith SP; Foley EH; Grande DJ
    J Dermatol Surg Oncol; 1990 Nov; 16(11):1012-6. PubMed ID: 2246406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.
    Allen KJ; Cappel MA; Killian JM; Brewer JD
    Int J Dermatol; 2014 Nov; 53(11):1395-403. PubMed ID: 24961583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell carcinoma recurring after radiotherapy: a unique, difficult treatment subclass of recurrent basal cell carcinoma.
    Smith SP; Grande DJ
    J Dermatol Surg Oncol; 1991 Jan; 17(1):26-30. PubMed ID: 1991878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of basosquamous carcinoma after Mohs micrographic surgery.
    Skaria AM
    Dermatology; 2010; 221(4):352-5. PubMed ID: 20924160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mohs' micrographic surgery for basal cell carcinoma.
    Lawrence CM
    Clin Exp Dermatol; 1999 Mar; 24(2):130-3. PubMed ID: 10233670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study.
    Sin CW; Barua A; Cook A
    Int J Dermatol; 2016 Sep; 55(9):1044-7. PubMed ID: 27152747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mohs micrographic surgery: a synopsis.
    Stone JL
    Hawaii Med J; 1993 May; 52(5):134-9. PubMed ID: 8320092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
    Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
    Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New primary basal cell carcinomas arising in skin flaps following Mohs micrographic surgery for primary and recurrent basal cell carcinoma.
    Wagner RF
    J Dermatol Surg Oncol; 1990 Nov; 16(11):1044-7. PubMed ID: 2246410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inserting ex vivo fluorescence confocal microscopy perioperatively in Mohs micrographic surgery expedites bedside assessment of excision margins in recurrent basal cell carcinoma.
    Longo C; Ragazzi M; Castagnetti F; Gardini S; Palmieri T; Lallas A; Moscarella E; Piana S; Pellacani G; Zalaudek I; Argenziano G
    Dermatology; 2013; 227(1):89-92. PubMed ID: 24008980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional review of Mohs slides to optimize Mohs micrographic surgery.
    van Lee CB; Graafland B; Koljenović S; Neumann HA; Nasserinejad K; Nijsten TE; van den Bos RR; Munte K
    Br J Dermatol; 2015 Jul; 173(1):123-7. PubMed ID: 25708878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
    Cerci FB; Kubo EM; Werner B; Tolkachjov SN
    J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery.
    Ratner D; Bagiella E
    Dermatol Surg; 2003 Sep; 29(9):899-903. PubMed ID: 12930329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mohs surgery vs primary excision for eyelid BCCs.
    Tildsley J; Diaper C; Herd R
    Orbit; 2010 Jun; 29(3):140-5. PubMed ID: 20497079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micronodular basal cell carcinoma. A deceptive histologic subtype with frequent clinically undetected tumor extension.
    Hendrix JD; Parlette HL
    Arch Dermatol; 1996 Mar; 132(3):295-8. PubMed ID: 8607634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical margin marking for high-risk basal cell carcinomas of the cephalic region: a single-centre experience.
    Cecchi R; Bartoli L; Brunetti L; Pavesi M; Rapicano V
    G Ital Dermatol Venereol; 2011 Apr; 146(2):79-84. PubMed ID: 21505392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma.
    Paoli J; Daryoni S; Wennberg AM; Mölne L; Gillstedt M; Miocic M; Stenquist B
    Acta Derm Venereol; 2011 Oct; 91(6):689-93. PubMed ID: 21681360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.